66.79BMarket Cap15.85P/E (TTM)
167.61High160.91Low12.54KlotVolume163.26Open161.92Pre Close207.29MTurnover1.39%Turnover RatioLossP/E (Static)401.00MShares215.7152wk High13.83P/B15.07BFloat Cap76.3252wk Low194.30Limit Up90.45MShs Float215.71Historical High129.54Limit Down4.14%Amplitude28.75Historical Low--Dividend TTM165.24Avg Price5.25KlotAsk--Div YieldTTM100Lot Size5.45KlotBid
Sichuan Biokin Pharmaceutical Stock Forum
December 22, 2023
2142.HK
1.56
(-2.5%)
The biopharma company has marked out a path to profitability by licensing its drug expertise and antibody platforms to partners such as Pfizer
Key Takeaways:
Nona Biosciences, a subsidiary of HBM Holdings, has struck a licensing-out deal with a Pfizer-owned biotech for an initial sum of $53 million and milestone payments of up to $1.05 billion
HBM Holdin...
No comment yet